Management and outcome in adult intramedullary spinal cord tumours: a 20-year single institution experience
- PMID: 25495874
- PMCID: PMC4302119
- DOI: 10.1186/1756-0500-7-908
Management and outcome in adult intramedullary spinal cord tumours: a 20-year single institution experience
Abstract
Background: Several uncertainties remain concerning the management of intramedullary spinal cord tumours (IMSCTs). These include the timing and extent of resection, its interrelated functional outcome, and the adequate use and timing of radiation therapy and/or chemotherapy. In this retrospective study we report on all adult cases involving IMSCTs treated from 1987 to 2007 in our institution to validate our treatment strategy for IMSCTs. Pre- and post-operative functional performance was classified according to the McCormick scale.
Results: A total of 70 adult cases with IMSCTs consisting of ependymoma (39), astrocytoma (11), carcinoma metastasis (8), haemangioblastoma (5), cavernoma (3) and others (4) were reviewed. Mean age was 46.8 years (range, 18-79 years), and mean follow-up was 4.5 years (range, 1-195 months). The proportion of localisation in descending order was thoracic (36%), cervical (33%), cervicothoracic (19%) and conus region (13%), with 45 gross total resections, 22 partial resections and three biopsies. Surgery-related morbidity with worsening postoperative symptoms occurred immediately in 13 patients (18.6%). The preoperative McCormick grade correlated significantly with the early postoperative grade and the grade at follow-up (χ2-test; p=0.001). None of the patients with preserved intraoperative evoked potentials exhibited significant postoperative deterioration. The degree of resection was correlated with progression-free survival (Duncan test; p=0.05). Most patients with malignant tumours, namely anaplastic ependymoma (3), astrocytoma (2) or metastatic lesions (5), underwent postoperative radiation therapy. Six patients (one anaplastic ependymoma, two anaplastic astrocytomas and three metastatic lesions) received postoperative chemotherapy.
Conclusions: IMSCTs should be operated on when symptoms are mild. We recommend evoked potential-guided microsurgical total resection of ependymomas and other benign lesions; partial resection or biopsy followed by adjuvant therapy should be confined to patients with high-grade astrocytomas, whereas resection or biopsy with adjuvant therapy is the best option for metastatic lesions.
Figures



Similar articles
-
Factors associated with progression-free survival and long-term neurological outcome after resection of intramedullary spinal cord tumors: analysis of 101 consecutive cases.J Neurosurg Spine. 2009 Nov;11(5):591-9. doi: 10.3171/2009.4.SPINE08159. J Neurosurg Spine. 2009. PMID: 19929363
-
Surgical results of intramedullary spinal cord tumor with spinal cord monitoring to guide extent of resection.J Neurosurg Spine. 2009 May;10(5):404-13. doi: 10.3171/2009.2.SPINE08698. J Neurosurg Spine. 2009. PMID: 19442001
-
Surgery for spinal intramedullary tumors: technique, outcome and factors affecting resectability.Neurosurg Rev. 2018 Apr;41(2):503-511. doi: 10.1007/s10143-017-0879-z. Epub 2017 Jul 17. Neurosurg Rev. 2018. PMID: 28717891
-
Neurosurgical management of intramedullary spinal cord tumors in children.Pediatr Neurosurg. 2007;43(3):222-35. doi: 10.1159/000098835. Pediatr Neurosurg. 2007. PMID: 17409792 Review.
-
Predictive Factors of Long-Term Neurologic Outcome and Progression-Free Survival in Intramedullary Spinal Cord Tumors: A 10-year Single-Center Cohort Study and Review of the Literature.World Neurosurg. 2024 Jul;187:e94-e106. doi: 10.1016/j.wneu.2024.04.024. Epub 2024 Apr 10. World Neurosurg. 2024. PMID: 38608817 Review.
Cited by
-
Spinal ependymal tumors.Neurooncol Adv. 2024 Feb 13;6(Suppl 3):iii57-iii65. doi: 10.1093/noajnl/vdad138. eCollection 2024 Oct. Neurooncol Adv. 2024. PMID: 39430387 Free PMC article. Review.
-
Current Trends in the Surgical Management of Intramedullary Tumors: A Multicenter Study of 1,033 Patients by the Neurospinal Society of Japan.Neurospine. 2022 Jun;19(2):441-452. doi: 10.14245/ns.2244156.078. Epub 2022 Jun 30. Neurospine. 2022. PMID: 35793935 Free PMC article.
-
Effect of race, sex, and socioeconomic factors on overall survival following the resection of intramedullary spinal cord tumors.J Neurooncol. 2023 Aug;164(1):75-85. doi: 10.1007/s11060-023-04373-9. Epub 2023 Jul 21. J Neurooncol. 2023. PMID: 37479956
-
A novel lateral myelotomy approach for the treatment of lateral or ventrolateral spinal gliomas.Acta Neurochir (Wien). 2024 May 29;166(1):237. doi: 10.1007/s00701-024-06139-2. Acta Neurochir (Wien). 2024. PMID: 38809310
-
Long-term quality of life and functional outcomes in adults surgically treated for intramedullary spinal cord tumor.Front Psychol. 2023 Apr 20;14:1136223. doi: 10.3389/fpsyg.2023.1136223. eCollection 2023. Front Psychol. 2023. PMID: 37151327 Free PMC article.
References
-
- Klekamp J, Samii M. Surgery of spinal tumors. Berlin – Heidelberg: Springer; 2007.
-
- Raco A, Esposito V, Lenzi J, Piccirilli M, Delfini R, Cantore G. Long-term follow-up of intramedullary spinal cord tumors: a series of 202 cases. Neurosurgery. 2005;56(5):972–981. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources